Business Description
Percheron Therapeutics Ltd
NAICS : 325412
SIC : 2834
ISIN : AU0000317281
Description
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1074.56 | |||||
| Equity-to-Asset | 0.82 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -12.6 | |||||
| 3-Year EPS without NRI Growth Rate | -9.4 | |||||
| 3-Year FCF Growth Rate | -10.1 | |||||
| 3-Year Book Growth Rate | 18.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -80 | |||||
| 12-1 Month Momentum % | -83.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.66 | |||||
| Quick Ratio | 5.66 | |||||
| Cash Ratio | 4.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11 | |||||
| Shareholder Yield % | -16.69 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -76.64 | |||||
| ROA % | -63.88 | |||||
| ROIC % | -2685.11 | |||||
| ROC (Joel Greenblatt) % | -10226.33 | |||||
| ROCE % | -90.21 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.06 | |||||
| EV-to-EBIT | -3.79 | |||||
| EV-to-EBITDA | -3.82 | |||||
| EV-to-FCF | -4.69 | |||||
| Earnings Yield (Greenblatt) % | -26.39 | |||||
| FCF Yield % | -15.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ATHJF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Percheron Therapeutics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.01 | ||
| Beta | 0.27 | ||
| Volatility % | 80.69 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.01 | ||
| 12-1 Month Momentum % | -83.33 | ||
| 52-Week Range ($) | 0.01 - 0.06 | ||
| Shares Outstanding (Mil) | 901.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Percheron Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Percheron Therapeutics Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Percheron Therapeutics Ltd Frequently Asked Questions
What is Percheron Therapeutics Ltd(ATHJF)'s stock price today?
The current price of ATHJF is $0.01. The 52 week high of ATHJF is $0.06 and 52 week low is $0.01.
When is next earnings date of Percheron Therapeutics Ltd(ATHJF)?
The next earnings date of Percheron Therapeutics Ltd(ATHJF) is .
Does Percheron Therapeutics Ltd(ATHJF) pay dividends? If so, how much?
Percheron Therapeutics Ltd(ATHJF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers